BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Phenylketonuria readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Phenylketonuria\, fro
 m ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06302348-10816@assetmemo.bio
DTSTAMP:20261121T005412Z
DTSTART;VALUE=DATE:20310228
DTEND;VALUE=DATE:20310301
SUMMARY:Sepiapterin: Phase 3 readout est. (NCT06302348)
DESCRIPTION:Sepiapterin\, phase 3\, Phenylketonuria.\nStudy: A Study of Sep
 iapterin in Participants With Phenylketonuria (PKU)\nEstimated primary com
 pletion: 28 February 2031. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/sepiapterin#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT06302348
URL:https://assetmemo.bio/drug/sepiapterin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
